发明名称 Combination cancer therapy with hsp90 inhibitory compounds
摘要 <p>622713 Disclosed is a method for treating a subject with a cancer selected from breast cancer, ovarian cancer and prostate cancer, comprising administering to the subject an effective amount of paclitaxel or docetaxel and an effective amount of: 3-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(1-methyl-indol-5-yl)-5-hydroxy-[1,2,4]triazole or 5-hydroxy-4-(5-hydroxy-4-(1-methyl-1H-indol-5-yl)-4H-1,2,4-triazol-3-yl)-2-isopropylphenyl dihydrogen phosphate a tautomer, or a pharmaceutically acceptable salt thereof.</p>
申请公布号 NZ622713(A) 申请公布日期 2015.07.31
申请号 NZ20100622713 申请日期 2010.10.19
申请人 SYNTA PHARMACEUTICALS CORP. 发明人 FOLEY KEVIN PAUL;PROIA DAVID;BLACKMAN RONALD K
分类号 A61K31/4196;A61K31/337;A61K45/06;A61P35/00 主分类号 A61K31/4196
代理机构 代理人
主权项
地址